Article

The New York Times on 2019-02-12 23:44

F.D.A. Panel Recommends New Depression Treatment

The active ingredients of ketamine, a popular club drug, show promise in battling deep despair.

Related news

FDA panel recommends approving first peanut allergy treatment The Day
New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds The New York Times
Expert panel recommends new shingles vaccine that gives increased protection Washington Post
United States , King , Seattle , Washington
Expert panel recommends new options for HIV prevention The New York Times
United States , Texas
CDC Panel Recommends New Covid Boosters For Most Americans Forbes
United States
Ferguson panel recommends reforms The Toledo Blade
Missouri
F.D.A. Approves New Drug for Flu The New York Times
Japan
F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots The New York Times
F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy The New York Times
F.D.A. Panel Recommends 2 R.S.V. Vaccines for Older Adults The New York Times
F.D.A. Panel Recommends Vaccine for Children 5 to 11 The New York Times
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market The New York Times
F.D.A. Panel Recommends Moderna Booster for Certain Groups The New York Times
F.D.A. Panel Recommends Booster for Many Moderna Vaccine Recipients The New York Times
F.D.A. Panel Recommends Covid Shots for Children 5 to 11 The New York Times
F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children The New York Times
F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants The New York Times
Controversial Alzheimer’s Drug Faces Critical Test Before F.D.A. Panel The New York Times
United States , Mayo Clinic , Zephyr
F.D.A. Approves New Treatment for Early Alzheimer’s The New York Times